195 related articles for article (PubMed ID: 35304527)
21. [How I manage polycythemia].
Lombardo G; Hafraoui K; Beguin Y; Vertenoeil G
Rev Med Liege; 2024 Feb; 79(2):110-115. PubMed ID: 38356428
[TBL] [Abstract][Full Text] [Related]
22. The Amelioration of Myelofibrosis with Thrombocytopenia by a JAK1/2 Inhibitor, Ruxolitinib, in a Post-polycythemia Vera Myelofibrosis Patient with a JAK2 Exon 12 Mutation.
Ikeda K; Ueda K; Sano T; Ogawa K; Ikezoe T; Hashimoto Y; Morishita S; Komatsu N; Ohto H; Takeishi Y
Intern Med; 2017; 56(13):1705-1710. PubMed ID: 28674362
[TBL] [Abstract][Full Text] [Related]
23. Phenotypic variations and new mutations in JAK2 V617F-negative polycythemia vera, erythrocytosis, and idiopathic myelofibrosis.
Williams DM; Kim AH; Rogers O; Spivak JL; Moliterno AR
Exp Hematol; 2007 Nov; 35(11):1641-6. PubMed ID: 17920755
[TBL] [Abstract][Full Text] [Related]
24. Erythrocytosis due to presumed polycythemia vera.
Patell R; Theil K; Lichtin A
Cleve Clin J Med; 2016 Sep; 83(9):648-53. PubMed ID: 27618352
[No Abstract] [Full Text] [Related]
25. Polycythemia vera: scientific advances and current practice.
Tefferi A; Spivak JL
Semin Hematol; 2005 Oct; 42(4):206-20. PubMed ID: 16210034
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of diagnostic criteria in polycythemia vera.
Pearson TC
Semin Hematol; 2001 Jan; 38(1 Suppl 2):21-4. PubMed ID: 11242598
[TBL] [Abstract][Full Text] [Related]
27. Quantification of PRV-1 mRNA distinguishes polycythemia vera from secondary erythrocytosis.
Klippel S; Strunck E; Temerinac S; Bench AJ; Meinhardt G; Mohr U; Leichtle R; Green AR; Griesshammer M; Heimpel H; Pahl HL
Blood; 2003 Nov; 102(10):3569-74. PubMed ID: 12893745
[TBL] [Abstract][Full Text] [Related]
28. Detection of JAK2 exon 12 mutations in 15 patients with JAK2V617F negative polycythemia vera.
Schnittger S; Bacher U; Haferlach C; Geer T; Müller P; Mittermüller J; Petrides P; Schlag R; Sandner R; Selbach J; Slawik HR; Tessen HW; Wehmeyer J; Kern W; Haferlach T
Haematologica; 2009 Mar; 94(3):414-8. PubMed ID: 19252176
[TBL] [Abstract][Full Text] [Related]
29. JAK2 unmutated erythrocytosis: 2023 Update on diagnosis and management.
Gangat N; Szuber N; Tefferi A
Am J Hematol; 2023 Jun; 98(6):965-981. PubMed ID: 36966432
[TBL] [Abstract][Full Text] [Related]
30. Somatic JAK-2 V617F Mutational Analysis in Polycythemia Rubra Vera: a Tertiary Care Center Experience.
Sultan S; Irfan SM; Khan SR
Asian Pac J Cancer Prev; 2016; 17(3):1053-5. PubMed ID: 27039724
[TBL] [Abstract][Full Text] [Related]
31. Congenital erythrocytosis and polycythemia vera in childhood and adolescence.
Cario H; Schwarz K; Debatin KM; Kohne E
Klin Padiatr; 2004; 216(3):157-62. PubMed ID: 15175960
[TBL] [Abstract][Full Text] [Related]
32. Polycythemia vera.
Landolfi R; Nicolazzi MA; Porfidia A; Di Gennaro L
Intern Emerg Med; 2010 Oct; 5(5):375-84. PubMed ID: 20237866
[TBL] [Abstract][Full Text] [Related]
33. Elevated serum erythropoietin levels in patients with Budd-Chiari syndrome secondary to polycythemia vera: clinical implications for the role of JAK2 mutation analysis.
Thurmes PJ; Steensma DP
Eur J Haematol; 2006 Jul; 77(1):57-60. PubMed ID: 16827884
[TBL] [Abstract][Full Text] [Related]
34. Characteristics of JAK2 unmutated erythrocytosis: Distinctive traits between polycythemia vera and non-polycythemia vera patients.
Ernest V; Abbou N; Tichadou A; Arcani R; Venton G
Eur J Intern Med; 2023 Jan; 107():113-115. PubMed ID: 36096924
[No Abstract] [Full Text] [Related]
35. JAK2 exon 12 mutations in cases with JAK2V617F-negative polycythemia vera and primary myelofibrosis.
Maddali M; Kulkarni UP; Ravindra N; Jajodia E; Arunachalam AK; Suresh H; Venkatraman A; George B; Mathews V; Balasubramanian P
Ann Hematol; 2020 May; 99(5):983-989. PubMed ID: 32277273
[TBL] [Abstract][Full Text] [Related]
36. Proposal for revised diagnostic criteria of essential thrombocythemia and polycythemia vera by the Thrombocythemia Vera Study Group.
Michiels JJ; Juvonen E
Semin Thromb Hemost; 1997; 23(4):339-47. PubMed ID: 9263350
[TBL] [Abstract][Full Text] [Related]
37. Secondary causes of elevated hemoglobin in patients undergoing molecular testing for suspected polycythemia vera in southwestern Ontario: a chart review.
Chin-Yee B; Matyashin M; Cheong I; Bhai P; Lazo-Langner A; Almanaseer A; Kawata E; Levy MA; Stuart A; Lin H; Chin-Yee I; Sadikovic B; Hsia C
CMAJ Open; 2022; 10(4):E988-E992. PubMed ID: 36347562
[TBL] [Abstract][Full Text] [Related]
38. The clinical and laboratory evaluation of the patient with erythrocytosis.
Lee G; Arcasoy MO
Eur J Intern Med; 2015 Jun; 26(5):297-302. PubMed ID: 25837692
[TBL] [Abstract][Full Text] [Related]
39. The classification and diagnosis of erythrocytosis.
McMullin MF
Int J Lab Hematol; 2008 Dec; 30(6):447-59. PubMed ID: 18823397
[TBL] [Abstract][Full Text] [Related]
40. Erythrocytosis: Diagnosis and investigation.
Noumani I; Harrison CN; McMullin MF
Int J Lab Hematol; 2024 May; 46 Suppl 1():55-62. PubMed ID: 38695361
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
